Lv41
450 积分 2024-09-16 加入
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
1个月前
已完结
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner
1个月前
已完结
Tirzepatide: First Approval
1个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2个月前
已完结
Dozens of new obesity drugs are coming: these are the ones to watch
2个月前
已完结
Transforming obesity: The advancement of multi-receptor drugs
2个月前
已完结
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
2个月前
已完结
GDF15 promotes weight loss by enhancing energy expenditure in muscle
2个月前
已完结
Glucagon-like peptide-1 analogs: Miracle drugs are blooming?
2个月前
已完结
皖公网安备34019202002308
